128 related articles for article (PubMed ID: 21645455)
1. [Expressions of c-Cbl, Cbl-b and EGFR and its role of prognosis in NSCLC].
Jiao X; Jin B; Qu X; Yan S; Hou K; Liu Y; Hu X
Zhongguo Fei Ai Za Zhi; 2011 Jun; 14(6):512-7. PubMed ID: 21645455
[TBL] [Abstract][Full Text] [Related]
2. E3 ubiquitin ligases Cbl-b and c-Cbl downregulate PD-L1 in EGFR wild-type non-small cell lung cancer.
Wang S; Xu L; Che X; Li C; Xu L; Hou K; Fan Y; Wen T; Qu X; Liu Y
FEBS Lett; 2018 Feb; 592(4):621-630. PubMed ID: 29364514
[TBL] [Abstract][Full Text] [Related]
3. LncRNA DUXAP9-206 directly binds with Cbl-b to augment EGFR signaling and promotes non-small cell lung cancer progression.
Zhu T; An S; Choy MT; Zhou J; Wu S; Liu S; Liu B; Yao Z; Zhu X; Wu J; He Z
J Cell Mol Med; 2019 Mar; 23(3):1852-1864. PubMed ID: 30515972
[TBL] [Abstract][Full Text] [Related]
4. Expression of c-Cbl, Cbl-b, and epidermal growth factor receptor in gastric carcinoma and their clinical significance.
Dong Q; Liu YP; Qu XJ; Hou KZ; Li LL
Chin J Cancer; 2010 Jan; 29(1):59-64. PubMed ID: 20038312
[TBL] [Abstract][Full Text] [Related]
5. Suppressed expression of Cbl-b by NF-κB mediates icotinib resistance in EGFR-mutant non-small-cell lung cancer.
Zhang T; Zheng C; Hou K; Wang J; Zhang Y; Fan Y; Zhao H; Qu X; Liu Y; Kang J; Che X; Hu X
Cell Biol Int; 2019 Feb; 43(2):98-107. PubMed ID: 29972257
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin ligase Cbl-b is involved in icotinib (BPI-2009H)-induced apoptosis and G1 phase arrest of EGFR mutation-positive non-small-cell lung cancer.
Mu X; Zhang Y; Qu X; Hou K; Kang J; Hu X; Liu Y
Biomed Res Int; 2013; 2013():726375. PubMed ID: 23586056
[TBL] [Abstract][Full Text] [Related]
7. Differential parsing of EGFR endocytic flux among parallel internalization pathways in lung cancer cells with EGFR-activating mutations.
Walsh AM; Lazzara MJ
Integr Biol (Camb); 2014 Mar; 6(3):312-23. PubMed ID: 24445374
[TBL] [Abstract][Full Text] [Related]
8. Expression and Comparison of Cbl-b in Lung Squamous Cell Carcinoma and Adenocarcinoma.
Li P; Liu H; Zhang Z; Lv X; Wang H; Ma J; Ma Z; Qu X; Teng YE
Med Sci Monit; 2018 Jan; 24():623-635. PubMed ID: 29384143
[TBL] [Abstract][Full Text] [Related]
9. Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL.
Tan YC; Mirzapoiazova T; Won BM; Zhu L; Srivastava MK; Vokes EE; Husain AN; Batra SK; Sharma S; Salgia R
Sci Rep; 2017 Aug; 7(1):9192. PubMed ID: 28835699
[TBL] [Abstract][Full Text] [Related]
10. [Hsp90AB1 Protein is Overexpressed in Non-small Cell Lung Cancer Tissues
and Associated with Poor Prognosis in Lung Adenocarcinoma Patients].
Wang M; Feng L; Li P; Han N; Gao Y; Xiao T
Zhongguo Fei Ai Za Zhi; 2016 Feb; 19(2):64-9. PubMed ID: 26903158
[TBL] [Abstract][Full Text] [Related]
11. [The expression of programmed death receptor 1 in non-small cell lung cancer and its clinicopathological features and prognosis showed a connection with epidermal growth factor receptor gene mutations].
Yin H; Liao CG; Wang YQ; Li Z; Fan LL; Qian ML; Lu N
Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):419-423. PubMed ID: 28635230
[No Abstract] [Full Text] [Related]
12. [Differential expressions of MDR-1, RRM-1, EGFR and ERCC-1 in primary tumors and metastatic lymph nodes of NSCLC patients].
Guo N; Li S; Zhang W; Yu C; Wang H; Zhang Y; Yu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):870-3. PubMed ID: 23948418
[TBL] [Abstract][Full Text] [Related]
13. miR-22-3p enhances the intrinsic regenerative abilities of primary sensory neurons via the CBL/p-EGFR/p-STAT3/GAP43/p-GAP43 axis.
Li B; Wang Z; Yu M; Wang X; Wang X; Chen C; Zhang Z; Zhang M; Sun C; Zhao C; Li Q; Wang W; Wang T; Zhang L; Ning G; Feng S
J Cell Physiol; 2020 May; 235(5):4605-4617. PubMed ID: 31663116
[TBL] [Abstract][Full Text] [Related]
14. Erbin interacts with c-Cbl and promotes tumourigenesis and tumour growth in colorectal cancer by preventing c-Cbl-mediated ubiquitination and down-regulation of EGFR.
Yao S; Zheng P; Wu H; Song LM; Ying XF; Xing C; Li Y; Xiao ZQ; Zhou XN; Shen T; Chen L; Liu YH; Lai MD; Mei L; Gao TM; Li JM
J Pathol; 2015 May; 236(1):65-77. PubMed ID: 25521828
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of MACC1 and c-met expressions in non-small cell lung cancer].
Hu X; Fu X; Wen S; Zou X; Liu Y
Zhongguo Fei Ai Za Zhi; 2012 Jul; 15(7):399-403. PubMed ID: 22814258
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of RBM5, EGFR and KRAS mRNA and protein in non-small cell lung cancer tissues.
Liang H; Zhang J; Shao C; Zhao L; Xu W; Sutherland LC; Wang K
J Exp Clin Cancer Res; 2012 Apr; 31(1):36. PubMed ID: 22537942
[TBL] [Abstract][Full Text] [Related]
17. Expression of epidermal growth factor receptor (EGFR) and downstream-activated peptides in surgically excised non-small-cell lung cancer (NSCLC).
Mukohara T; Kudoh S; Yamauchi S; Kimura T; Yoshimura N; Kanazawa H; Hirata K; Wanibuchi H; Fukushima S; Inoue K; Yoshikawa J
Lung Cancer; 2003 Aug; 41(2):123-30. PubMed ID: 12871775
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of mutant p53, Ki-67, and TTF-1 and their correlation with EGFR mutation in patients with non-small cell lung cancer.
Zhu WY; Hu XF; Fang KX; Kong QQ; Cui R; Li HF; He JY; Zhang YK; Le HB
Histol Histopathol; 2019 Nov; 34(11):1269-1278. PubMed ID: 31062864
[TBL] [Abstract][Full Text] [Related]
19. Cbl-family ubiquitin ligases and their recruitment of CIN85 are largely dispensable for epidermal growth factor receptor endocytosis.
Ahmad G; Mohapatra BC; Schulte NA; Nadeau SA; Luan H; Zutshi N; Tom E; Ortega-Cava C; Tu C; Sanada M; Ogawa S; Toews ML; Band V; Band H
Int J Biochem Cell Biol; 2014 Dec; 57():123-34. PubMed ID: 25449262
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation, but not overexpression, of epidermal growth factor receptor is associated with poor prognosis of non-small cell lung cancer patients.
Kanematsu T; Yano S; Uehara H; Bando Y; Sone S
Oncol Res; 2003; 13(5):289-98. PubMed ID: 12688680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
